GlassScriptPhysician profile
Prabhjot Kaur Grewal
NPI 1770142630
$5,803.54
in general payments reported to CMS, 2019-2025
23 companies · $951 in 2025
The $951 reported for 2025 was more than what 84% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $48.09 · 2022: $490 · 2023: $1,519 · 2024: $2,796 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,924 · Travel and Lodging: $992 · Education: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,924.48 |
| Travel and Lodging | $992.44 |
| Education | $348.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $1,940.33 | 2022-2024 | Amvia Edge, Selectra, Solia |
| Boston Scientific Corporation | $1,537.02 | 2022-2025 | Electrophysiology Cable, Farapulse, Rotapro |
| Novartis Pharmaceuticals Corporation | $496.94 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $305.25 | 2023-2025 | Onpattro, Amvuttra |
| Heartflow, INC. | $221.12 | 2025 | |
| Astellas Pharma US INC | $199.98 | 2023 | |
| Medtronic, INC. | $188.56 | 2024-2025 | Hawkone |
| Shockwave Medical, INC | $127.66 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Baxter Healthcare | $116.21 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.50 | 2023-2024 | Jardiance |
| Daiichi Sankyo INC. | $80.23 | 2023 | Injectafer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.92 | 2020-2023 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $71.70 | 2024 | Arcalyst |
| Pfizer INC. | $51.11 | 2024 | |
| Ancora Heart, INC. | $49.00 | 2023-2024 | Accucinch |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $47.82 | 2024 | Verquvo |
| Kestra Medical Technology Services, INC. | $44.25 | 2024 | Assure Wcd |
| Abiomed | $38.97 | 2022 | |
| Janssen Pharmaceuticals, INC | $35.85 | 2023-2024 | Xarelto |
| Terumo Medical Corporation | $28.29 | 2023 | Glidesheath Slender, Tr Band, Optitorque |
| Amgen INC. | $21.15 | 2024 | Repatha |
| Lilly USA, LLC | $17.84 | 2022 | |
| Philips North America LLC | $15.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabhjot Grewal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.